 |
BULLETIN |  |
CANADIAN GENETIC DISEASES NETWORK |
||
NETWORK SCIENTISTS MAKE BREAKTHROUGHS IN THREE GENETIC DISEASES
Montreal & Toronto - February 1, 1995: Network scientists Dr. Diane Cox and Dr. John Dick of Toronto's Hospital for Sick Children and Dr. Steven Narod of McGill University's Montreal General Hospital have recently published news of three research breakthroughs in genetic-related diseases.
The February 1 issues of Nature Genetics, Human Molecular Genetics and Nature Medicine respectively carried the news.
Just over one year ago, Dr. Diane Cox's team cloned the gene for Wilson disease, a devastating syndrom which causes copper poisoning of the liver and the brain. In her latest paper, Dr. Cox has announced the discovery of 25 new mutations which, it is believed, will lead to very early diagnosis of the disease in childhood. Another important practical advance is the potential application of these mutations to screening for patients already suspected of having Wilson disease.
Said Dr. Cox "This changes the whole outlook on the diagnosis of liver disease in early childhood and provides a reliable predictive test in families where a diagnosis has been made." This discovery is of major importance because, unlike many childhood liver diseases, Wilson disease once identified is treatable. One in every 30,000 Canadians is believed to carry the defective gene.
Dr. John Dick has made a significance advance in the development of a unique gene therapy model for thalassemia and sickle cell anemia, both widespread and severe anemias. Dr. Dick and his team have transplanted into mice, human cells which carry the genetic deficiencies of these diseases. The cells develop into all blood lineages, including the same defective red blood cells as the anemia sufferer.
Explains Dr. Dick "The importance of this advance is that researchers will now be able to directly examine human cells prior to pre-clinical experiments."
He added "This is a good gene therapy model in that we can now assess gene transference into the damaged cells, measure gene expression, and finally follow correction of the red cell defect."
The model is viewed as a valuable stepping stone in anemia research.
Dr. Steven Narod, a member of the research team which recently isolated the breast cancer gene, BRCA1, is now focusing attention on prostate cancer, the most common cancer found in men in Canada.
A new study carried out by Dr. Narod and Dr. Fernand Labrie at the University of Laval has found that one in ten men who have brothers with prostate cancer are susceptible also to prostate cancer. Results from a group of over 6,000 randomly selected men between the ages of 50 and 80 showed that cancer was detected in 6% more of the group with brothers with cancer, than in the group with no brothers with cancer. The study also indicates that the cancers in the higher risk group can be detected early with the currently used prostate-specific antigen (PSA) blood screening test.
According to Dr. Narod, men with a family history of prostate cancer should be made aware of their increased risk. No significant excess risk appears to be associated with a father who has prostate cancer.
Dr. Cox, Dr. Dick and Dr. Narod are members of the Canadian Genetic Diseases Network, a consortium of 38 of Canada's leading geneticists who are linked with twelve universities across Canada, 13 core technology facilities, and 8 industrial partners to form an "institute without walls". The network carries a mandate under the federal government's Networks of Centres of Excellence Program to perform leading-edge research and to work with industry partners on detection and treatment of genetically-transmitted disease.
DISCOVERY OF WILSON DISEASE GENE
Toronto - December 1, 1993: Network scientists based at Toronto's Hospital for Sick Children and led by Network investigator Dr. Diane Cox have made a major breakthrough in genetic disease research in the discovery of the gene responsible for Wilson Disease.
The hereditary disease causes copper accumulation in the liver and brain, and leads to severe liver and neurological problems. Wilson Disease is a debilitating affliction, affecting 1 in 30,000 Canadians. It leads to liver destruction and cirrhosis, especially in children and adolescents, and speech and movement disorders, particularly in adolescents and young adults.
Discovery of the gene will result in earlier and more complete diagnosis and, eventually, more effective treatment of the disease and its symptoms. Current drug treatment has severe side effects and is sometimes ineffective when diagnosis is made late. If not identified in time, the only treatment for the disease has been organ transplant.
Dr. Cox, a geneticist and professor of molecular and medical genetics and paediatrics, said "A genetic test will mean that Wilson Disease can be quickly confirmed or eliminated for anyone with signs of liver disease. If more physicians become aware of the disease, the same can be done for any adults suffering from characteristic neurological problems".
The results of the discovery were published in the December 1 edition of the scientific jounal Nature Genetics.
Dr. Michael Hayden, Director of the Canadian Genetic Diseases Network which provided funding support for the research said, "The Network's facilities and collaborative systems across Canada fueled the extremely rapid progress in discovering the cause of Wilson Disease and will play a major in the continuing research for treatments."
The Canadian Genetic Diseases Network is a consortium of 38 of Canada's leading geneticists who are linked with nine universities across Canada and 10 core technology facilities to form an "institute without walls". The network carries a mandate under the federal government's Networks of Centres of Excellence Program to perform leading-edge research and to work with industry partners on detection and treatment of genetically-transmitted disease.
Montreal & Toronto - February 1, 1995: Network scientists Dr. Diane Cox and Dr. John Dick of Toronto's Hospital for Sick Children and Dr. Steven Narod of McGill University's Montreal General Hospital have recently published news of three research breakthroughs in genetic-related diseases.
The February 1 issues of Nature Genetics, Human Molecular Genetics and Nature Medicine respectively carried the news.
Just over one year ago, Dr. Diane Cox's team cloned the gene for Wilson disease, a devastating syndrom which causes copper poisoning of the liver and the brain. In her latest paper, Dr. Cox has announced the discovery of 25 new mutations which, it is believed, will lead to very early diagnosis of the disease in childhood. Another important practical advance is the potential application of these mutations to screening for patients already suspected of having Wilson disease.
Said Dr. Cox "This changes the whole outlook on the diagnosis of liver disease in early childhood and provides a reliable predictive test in families where a diagnosis has been made." This discovery is of major importance because, unlike many childhood liver diseases, Wilson disease once identified is treatable. One in every 30,000 Canadians is believed to carry the defective gene.
Dr. John Dick has made a significance advance in the development of a unique gene therapy model for thalassemia and sickle cell anemia, both widespread and severe anemias. Dr. Dick and his team have transplanted into mice, human cells which carry the genetic deficiencies of these diseases. The cells develop into all blood lineages, including the same defective red blood cells as the anemia sufferer.
Explains Dr. Dick "The importance of this advance is that researchers will now be able to directly examine human cells prior to pre-clinical experiments."
He added "This is a good gene therapy model in that we can now assess gene transference into the damaged cells, measure gene expression, and finally follow correction of the red cell defect."
The model is viewed as a valuable stepping stone in anemia research.
Dr. Steven Narod, a member of the research team which recently isolated the breast cancer gene, BRCA1, is now focusing attention on prostate cancer, the most common cancer found in men in Canada.
A new study carried out by Dr. Narod and Dr. Fernand Labrie at the University of Laval has found that one in ten men who have brothers with prostate cancer are susceptible also to prostate cancer. Results from a group of over 6,000 randomly selected men between the ages of 50 and 80 showed that cancer was detected in 6% more of the group with brothers with cancer, than in the group with no brothers with cancer. The study also indicates that the cancers in the higher risk group can be detected early with the currently used prostate-specific antigen (PSA) blood screening test.
According to Dr. Narod, men with a family history of prostate cancer should be made aware of their increased risk. No significant excess risk appears to be associated with a father who has prostate cancer.
Dr. Cox, Dr. Dick and Dr. Narod are members of the Canadian Genetic Diseases Network, a consortium of 38 of Canada's leading geneticists who are linked with twelve universities across Canada, 13 core technology facilities, and 8 industrial partners to form an "institute without walls". The network carries a mandate under the federal government's Networks of Centres of Excellence Program to perform leading-edge research and to work with industry partners on detection and treatment of genetically-transmitted disease.
DISCOVERY OF WILSON DISEASE GENE
Toronto - December 1, 1993: Network scientists based at Toronto's Hospital for Sick Children and led by Network investigator Dr. Diane Cox have made a major breakthrough in genetic disease research in the discovery of the gene responsible for Wilson Disease.
The hereditary disease causes copper accumulation in the liver and brain, and leads to severe liver and neurological problems. Wilson Disease is a debilitating affliction, affecting 1 in 30,000 Canadians. It leads to liver destruction and cirrhosis, especially in children and adolescents, and speech and movement disorders, particularly in adolescents and young adults.
Discovery of the gene will result in earlier and more complete diagnosis and, eventually, more effective treatment of the disease and its symptoms. Current drug treatment has severe side effects and is sometimes ineffective when diagnosis is made late. If not identified in time, the only treatment for the disease has been organ transplant.
Dr. Cox, a geneticist and professor of molecular and medical genetics and paediatrics, said "A genetic test will mean that Wilson Disease can be quickly confirmed or eliminated for anyone with signs of liver disease. If more physicians become aware of the disease, the same can be done for any adults suffering from characteristic neurological problems".
The results of the discovery were published in the December 1 edition of the scientific jounal Nature Genetics.
Dr. Michael Hayden, Director of the Canadian Genetic Diseases Network which provided funding support for the research said, "The Network's facilities and collaborative systems across Canada fueled the extremely rapid progress in discovering the cause of Wilson Disease and will play a major in the continuing research for treatments."
The Canadian Genetic Diseases Network is a consortium of 38 of Canada's leading geneticists who are linked with nine universities across Canada and 10 core technology facilities to form an "institute without walls". The network carries a mandate under the federal government's Networks of Centres of Excellence Program to perform leading-edge research and to work with industry partners on detection and treatment of genetically-transmitted disease.